Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Srinivas

Showing results (661-670 of 671) with videos related to

Pageof 68
Sort By:
Clinical Pharmacokinetics|May 17, 2017
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy VolunteersKevinkumar A Kansagra, Deven Parmar, Rajendra H Jani, et al.
Circulation Research|April 30, 2019
Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences, David C Goff, Denis B Buxton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2019
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM studyStefan P Berger, Claudia Sommerer, Oliver Witzke, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Chiral methionine oxidation reagents reveal stereospecific proteome modificationsAngel Gonzalez-Valero, Annika C S Page, Jayde M Bertoch, et al.
Journal of Extracellular Vesicles|September 1, 2015
The NIH Extracellular RNA Communication ConsortiumAlexandra M Ainsztein, Philip J Brooks, Vivien G Dugan, et al.
Indian Journal of Dermatology|January 27, 2010
Efficacy and tolerability of cefditoren pivoxil in uncomplicated skin and skin structure infections in Indian patientsCharu Manaktala, Amit Kumar Singh, Manish Verma, et al.
Journal of the American Academy of Dermatology|April 8, 2014
Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III studyD S Krupashankar, Sunil Dogra, Mahendra Kura, et al.
Gene Therapy|July 1, 2026
Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promotersNicole Zielinska, Erin L Howard, Brenna A Y Stevens, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 8, 2025
Induction of immune tolerance in living related human leukocyte antigen-matched kidney transplantation: A phase 3 randomized clinical trialDixon B Kaufman, Sanjeev K Akkina, Mark D Stegall, et al.
Advances in Nutrition (Bethesda, Md.)|August 7, 2019
Perspective: Dietary Biomarkers of Intake and Exposure-Exploration with Omics ApproachesPadma Maruvada, Johanna W Lampe, David S Wishart, et al.
Pageof 68

Showing results (661-670 of 671) with videos related to

Sort By:
Pageof 68
Clinical Pharmacokinetics|May 17, 2017
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy VolunteersKevinkumar A Kansagra, Deven Parmar, Rajendra H Jani, et al.
Circulation Research|April 30, 2019
Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences, David C Goff, Denis B Buxton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2019
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM studyStefan P Berger, Claudia Sommerer, Oliver Witzke, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Chiral methionine oxidation reagents reveal stereospecific proteome modificationsAngel Gonzalez-Valero, Annika C S Page, Jayde M Bertoch, et al.
Journal of Extracellular Vesicles|September 1, 2015
The NIH Extracellular RNA Communication ConsortiumAlexandra M Ainsztein, Philip J Brooks, Vivien G Dugan, et al.
Indian Journal of Dermatology|January 27, 2010
Efficacy and tolerability of cefditoren pivoxil in uncomplicated skin and skin structure infections in Indian patientsCharu Manaktala, Amit Kumar Singh, Manish Verma, et al.
Journal of the American Academy of Dermatology|April 8, 2014
Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III studyD S Krupashankar, Sunil Dogra, Mahendra Kura, et al.
Gene Therapy|July 1, 2026
Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promotersNicole Zielinska, Erin L Howard, Brenna A Y Stevens, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 8, 2025
Induction of immune tolerance in living related human leukocyte antigen-matched kidney transplantation: A phase 3 randomized clinical trialDixon B Kaufman, Sanjeev K Akkina, Mark D Stegall, et al.
Advances in Nutrition (Bethesda, Md.)|August 7, 2019
Perspective: Dietary Biomarkers of Intake and Exposure-Exploration with Omics ApproachesPadma Maruvada, Johanna W Lampe, David S Wishart, et al.
Pageof 68